Protalix BioTherapeutics ... (PLX)
2.92
-0.04 (-1.35%)
At close: Apr 24, 2025, 3:59 PM
3.00
2.74%
Pre-market: Apr 25, 2025, 07:00 AM EDT
Protalix BioTherapeutics Revenue
Protalix BioTherapeutics reported an annual revenue of $53.4M, reflecting a -18.47% growth. For the quarter ending December 31, 2024, Protalix BioTherapeutics generated $18.22M in revenue.
Revenue (ttm)
$53.4M
Revenue Growth
-18.47%
Price / Sales Ratio
2.55
Revenue / Employee
$250.7K
Employees
213
Market Cap
227.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 53.4M | -18.47% |
| Dec 31, 2023 | 65.49M | +37.48% |
| Dec 31, 2022 | 47.64M | +24.22% |
| Dec 31, 2021 | 38.35M | -39.03% |
| Dec 31, 2020 | 62.9M | n/a |